Theradiag SA (PA:ALTHE) — Stock Price

€0.59 EUR
▼ -1.66% today

Theradiag SA (PA:ALTHE) is currently trading at €0.59 EUR, down 1.66% today. Over the past 52 weeks, shares have ranged between €0.43 and €0.87. This page tracks Theradiag SA's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ALTHE company net worth.

Theradiag SA (ALTHE) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Theradiag SA's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Theradiag SA Income Statement — Revenue, Profit & Earnings by Year

Theradiag SA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue €830.00K €1.82 Million €1.24 Million €1.48 Million €744.00K
Cost of Revenue €8.01 Million €2.90 Million €4.29 Million €6.02 Million €4.55 Million
Gross Profit €-7.18 Million €-1.08 Million €-3.05 Million €-4.54 Million €-3.81 Million
Research & Development €4.30 Million €3.82 Million €2.10 Million
SG&A €4.84 Million €4.81 Million
Total Operating Expenses €-223.00K €2.07 Million €3.22 Million €197.00K €2.79 Million
Operating Income €-6.96 Million €-3.15 Million €-6.31 Million €-4.74 Million €-4.29 Million
EBITDA €-6.96 Million €-4.49 Million €-5.74 Million €-4.40 Million €-4.15 Million
EBIT €-6.74 Million €-4.69 Million €-5.92 Million €-4.53 Million €-4.29 Million
Interest Expense €21.54K €31.45K €44.06K €136.00K €330.00K
Income Before Tax €-6.74 Million €-4.72 Million €-5.97 Million €-4.64 Million €-4.63 Million
Income Tax Expense €-984.00K €-1.05 Million €-1.00 Million €-883.00K €-722.00K
Net Income €-5.76 Million €-3.68 Million €-4.96 Million €-3.76 Million €-3.90 Million

Theradiag SA Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Theradiag SA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets €11.47 Million €18.66 Million €13.94 Million €11.83 Million €10.55 Million
Total Current Assets €8.27 Million €16.11 Million €9.35 Million €7.94 Million €6.99 Million
Cash & Equivalents
Short-term Investments €-21.82K €31.10K €31.10K €31.10K
Net Receivables €446.66K €3.61 Million €3.63 Million €1.23 Million €1.32 Million
Inventory €2.11 Million €3.05 Million €3.06 Million €2.64 Million €2.19 Million
Property, Plant & Equipment €127.34K €180.22K €249.58K
Goodwill €0.00 €0.00
Total Liabilities €11.47 Million €13.01 Million €13.40 Million €13.10 Million €13.78 Million
Total Current Liabilities €3.75 Million €6.73 Million €3.89 Million €3.21 Million €3.06 Million
Long-term Debt €1.30 Million €1.95 Million €2.51 Million €2.05 Million €2.71 Million
Net Debt €-2.88 Million €-5.86 Million €21.14K €-99.00K €1.74 Million
Total Stockholder Equity €-114.00 €5.65 Million €544.87K €-1.27 Million €-3.24 Million
Retained Earnings €-5.76 Million €-3.68 Million €-4.96 Million €-3.76 Million €-3.91 Million

Theradiag SA Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Theradiag SA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow €-2.91 Million €-2.48 Million €-5.27 Million €-3.88 Million €-3.32 Million
Capital Expenditures €102.00K €112.29K €322.68K €148.22K €131.93K
Free Cash Flow €-3.01 Million €-2.60 Million €-5.59 Million €-4.03 Million €-3.45 Million
Investing Cash Flow €-188.00K €-213.52K €-739.63K €-524.46K €-192.55K
Financing Cash Flow €-545.00K €7.99 Million €6.03 Million €4.56 Million €4.41 Million
Dividends Paid
Stock-Based Compensation
Depreciation €824.00K €2.64 Million €144.46K €131.12K €138.56K
Change in Cash €-3.64 Million €5.30 Million €27.32K €148.00K €891.01K

Theradiag SA Earnings History — EPS Actual vs. Analyst Estimates

Track Theradiag SA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Oct 26, 2026
Apr 27, 2026
Oct 30, 2025
Mar 25, 2025
Oct 30, 2024
Oct 11, 2023 0.00 0.00
Jul 31, 2023 0.07 0.00
Apr 28, 2023 -0.03 0.00